Since most of the patients with non-reactive elevated platelet count were ET and PV patients, we further investigated the relationship between JAK2 V167F mutation and blood cell counts in 185 ET and 57 PV patients, respectively, diagnosed strictly according to WHO diagnostic criteria. This evidence concerns the gene JAK2 and acquired polycythemia vera.